Literature DB >> 20429427

FOXL2: at the crossroads of female sex determination and ovarian function.

Bérénice A Benayoun1, Aurélie Dipietromaria, Claude Bazin, Reiner A Veitia.   

Abstract

The gene FOXL2 encodes a forkhead transcription factor whose mutations are responsible for the blepharophimosis ptosis epicanthus-inversus syndrome. This genetic disorder is characterized by eyelid and mild craniofacial abnormalities often in association with premature ovarian failure. FOXL2 orthologs are found throughout the animal phylum and its sequence is highly conserved in vertebrates. FOXL2 is one of the earliest ovarian markers and it offers, alongwith its targets, a model to study ovarian development and function. In this chapter, we review recent data concemingits mutations, targets, regulation and functions. Studies of the cellular consequences of FOXL2 mutations seem to indicate that aggregation is a common pathogenic mechanism. However, no reliable genotype/phenotype correlation has been established to predict the exact impact of point mutations in the coding region of FOXL2. FOXL2 has been suggested to be involved in the regulation of cholesterol homeostasis, steroid metabolism, apoptosis, reactive oxygen species detoxification and inflammation processes. Interestingly, all these processes are not equally affected by FOXL2 mutations. The elucidation of the impact of the FOXL2 function in the ovary will allow a better understanding of normal ovarian development and function as well as the pathogenic mechanisms underlying BPES.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20429427     DOI: 10.1007/978-1-4419-1599-3_16

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  7 in total

Review 1.  Pituitary gland development and disease: from stem cell to hormone production.

Authors:  Shannon W Davis; Buffy S Ellsworth; María Inés Peréz Millan; Peter Gergics; Vanessa Schade; Nastaran Foyouzi; Michelle L Brinkmeier; Amanda H Mortensen; Sally A Camper
Journal:  Curr Top Dev Biol       Date:  2013       Impact factor: 4.897

2.  Sexually dimorphic expression of foxl2 during gametogenesis in scallop Chlamys farreri, conserved with vertebrates.

Authors:  Xiao-Ling Liu; Zhi-Feng Zhang; Ming-Yu Shao; Jian-Guo Liu; Faiz Muhammad
Journal:  Dev Genes Evol       Date:  2012-07-03       Impact factor: 0.900

3.  Integrated analysis of the miRNA and mRNA expression profiles in Leiocassis longirostris at gonadal maturation.

Authors:  Han Zhao; Lu Zhang; Qiang Li; Zhongmeng Zhao; Yuanliang Duan; Zhipeng Huang; Hongyu Ke; Chao Liu; Huadong Li; Lu Liu; Jun Du; Zhen Wei; Chengyan Mou; Jian Zhou
Journal:  Funct Integr Genomics       Date:  2022-04-25       Impact factor: 3.674

4.  Integrated analysis of mRNA-seq and miRNA-seq reveals the potential roles of sex-biased miRNA-mRNA pairs in gonad tissue of dark sleeper (Odontobutis potamophila).

Authors:  Cheng Zhao; Guosong Zhang; Shaowu Yin; Zecheng Li; Qintao Wang; Shuqiao Chen; Guoqin Zhou
Journal:  BMC Genomics       Date:  2017-08-14       Impact factor: 3.969

5.  Genome-wide differences in DNA methylation changes in caprine ovaries between oestrous and dioestrous phases.

Authors:  Xiaopeng An; Haidong Ma; Peng Han; Chao Zhu; Binyun Cao; Yueyu Bai
Journal:  J Anim Sci Biotechnol       Date:  2018-12-04

6.  Functional exploration of the adult ovarian granulosa cell tumor-associated somatic FOXL2 mutation p.Cys134Trp (c.402C>G).

Authors:  Bérénice A Benayoun; Sandrine Caburet; Aurélie Dipietromaria; Adrien Georges; Barbara D'Haene; P J Eswari Pandaranayaka; David L'Hôte; Anne-Laure Todeschini; Sankaran Krishnaswamy; Marc Fellous; Elfride De Baere; Reiner A Veitia
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

7.  The sex-specific transcriptome of the hermaphrodite sparid sharpsnout seabream (Diplodus puntazzo).

Authors:  Tereza Manousaki; Alexandros Tsakogiannis; Jacques Lagnel; Elena Sarropoulou; Jenny Z Xiang; Nikos Papandroulakis; Constantinos C Mylonas; Costas S Tsigenopoulos
Journal:  BMC Genomics       Date:  2014-08-06       Impact factor: 3.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.